Patent directory · USPTO A61K / A61P
Patents matching “Alnylam Pharmaceuticals, Inc.”
376 pharma patents match "Alnylam Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 376 pharmaceutical patents matching "Alnylam Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10077444
Compositions and methods for inhibiting expression of the LECT2 gene
granted -
US 10060921
Methods of treating transthyretin (TTR) mediated amyloidosis
granted -
US 10030244
Serpina1 iRNA compositions and methods of use thereof
granted -
US 9999673
PEGylated lipids and their use for drug delivery
granted -
US 9982263
Conserved HBV and HCV sequences useful for gene silencing
granted -
US 9970006
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
granted -
US 9963700
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
US 9957507
Compositions and methods for inhibiting expression of mutant EGFR gene
granted -
US 9944671
Compositions and methods directed to treating liver fibrosis
granted -
US 9932593
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
granted -
US 9902955
Method and medicament for inhibiting the expression of a given gene
granted -
US 9868950
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
granted -
US 9867882
Carbohydrate conjugates as delivery agents for oligonucleotides
granted -
US 9850488
Complement component C5 iRNA compositions and methods of use thereof
granted -
US 9822365
Compositions and methods for inhibiting expression of the PCSK9 gene
granted -
US 9796974
Modified RNAi agents
granted -
US 9783806
TMPRSS6 iRNA compositions and methods of use thereof
granted -
US 9771591
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 9708615
Therapeutic compositions
granted -
US 9701963
Complement component C5 iRNA compositions and methods of use thereof
granted -
US 9687448
Nucleic acid lipid particle formulations
granted -
US 9682922
Biodegradable lipids for the delivery of active agents
granted -
US 9631193
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 9587240
Compositions and methods for inhibiting expression of a target gene
granted